Diversified Healthcare Trust (DHC)
NASDAQ (NGS) 
Summary
DHC Chart
People also search for
Diversified Healthcare Trust: A Cautious Buy
Diversified Healthcare Trust is rated 'Buy' as fundamentals and balance sheet have improved despite recent share price gains. Q2 2026 saw SHOP NOI up 37.2% YoY and margin expansion, with normalized FFO surging 109.4% to $0.16/share. DHC's deleveraging is notable: net debt to adjusted EBITDAre fell to 7.1x, with no major maturities until 2028 and $270M in liquidity.
Diversified Healthcare Trust (DHC) Q2 2026 Earnings Call Transcript
Diversified Healthcare Trust (DHC) Q2 2026 Earnings Call Transcript
Diversified Healthcare Trust Q2 Earnings Call Highlights
Diversified Healthcare Trust NASDAQ: DHC reported second-quarter results marked by higher senior housing profitability, continued occupancy and pricing gains, and reduced leverage, while reaffirming the full-year guidance it raised in June.
Diversified Healthcare Trust Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 610 | $2,008.96 | $5,587.6 | $3,578.64 | 178.13% |
| NA Nizar Araji National Bank Of Canada /FI/ | 4,000 | $12,378.85 | $35,280 | $22,901.15 | 185% |
| BG Bart Gancher Intech Investment Management LLC | 58,058 | $138,233.8 | $512,071.56 | $373,837.76 | 270.44% |
| JM John Malone Amundi | 281,426 | $1.35M | $2.37M | $1.01M | 74.88% |
 Point72 Asset Management LP Point72 Asset Management LP | 110,000 | $1.02M | $921,800 | -$101,200 | -9.89% |
Diversified Healthcare Trust Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MD Michael Diana Maxim Group | 18,667.55 | $149,489.84 | $149,713.76 | $223.92 | 0.15% |
Diversified Healthcare Trust (DHC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Diversified Healthcare Trust ever had a stock split?
Diversified Healthcare Trust Profile
| Health Care REITs Industry | Real Estate Sector | Christopher J. Bilotto CEO | NASDAQ (NGS) Exchange | 25525P107 CUSIP |
| US Country | 600 Employees | 20 Jul 2026 Last Dividend | - Last Split | 22 Feb 2016 IPO Date |
Overview
DHC, also recognized as a real estate investment trust (REIT), focuses primarily on the ownership of properties that are significant in the healthcare and wellness industry. This includes medical office and life science properties, senior living communities, and wellness centers across the United States. The operations of DHC are expertly managed by the operating subsidiary of The RMR Group Inc. This group is an alternative asset management company with its headquarters located in Newton, MA, indicating a strong backing in terms of management expertise and financial stability.
Products and Services
- Medical Office and Life Science Properties
- Senior Living Communities
- Wellness Centers
These are properties leased to institutions, organizations, or individuals in the healthcare and scientific research sectors. These spaces are designed to meet the specialized needs of medical practitioners, researchers, and healthcare service providers, ensuring that they operate in environments that enhance their ability to provide care and conduct important research.
DHC offers real estate solutions catering specifically to the senior citizen demographic. These communities are designed to provide comfortable living options for older adults, along with various amenities and services tailored to their needs. This can range from independent living situations to more comprehensive care options, ensuring a quality lifestyle for the elderly population.
Recognizing the growing emphasis on wellness and preventive healthcare, DHC invests in properties used as wellness centers. These centers focus on offering services and programs aimed at enhancing physical, mental, and emotional well-being, supporting the overall health of the community they serve.
